| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 5.11e-05 | 37 | 39 | 3 | GO:0061631 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 8.05e-05 | 43 | 39 | 3 | GO:0061650 | |
| Domain | Dynamin_central | 6.02e-05 | 6 | 38 | 2 | IPR000375 | |
| Domain | Dynamin_M | 6.02e-05 | 6 | 38 | 2 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 6.02e-05 | 6 | 38 | 2 | IPR019762 | |
| Domain | GED | 6.02e-05 | 6 | 38 | 2 | SM00302 | |
| Domain | GED_dom | 6.02e-05 | 6 | 38 | 2 | IPR020850 | |
| Domain | GED | 6.02e-05 | 6 | 38 | 2 | PF02212 | |
| Domain | GED | 6.02e-05 | 6 | 38 | 2 | IPR003130 | |
| Domain | GED | 6.02e-05 | 6 | 38 | 2 | PS51388 | |
| Domain | G_DYNAMIN_1 | 8.41e-05 | 7 | 38 | 2 | PS00410 | |
| Domain | DYNc | 8.41e-05 | 7 | 38 | 2 | SM00053 | |
| Domain | G_DYNAMIN_dom | 3.61e-04 | 14 | 38 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 3.61e-04 | 14 | 38 | 2 | PS51718 | |
| Domain | Dynamin_SF | 4.16e-04 | 15 | 38 | 2 | IPR022812 | |
| Domain | Dynamin_GTPase | 4.16e-04 | 15 | 38 | 2 | IPR001401 | |
| Domain | Dynamin_N | 4.16e-04 | 15 | 38 | 2 | PF00350 | |
| Domain | Ubiquitin-rel_dom | 5.18e-04 | 184 | 38 | 4 | IPR029071 | |
| Domain | Bromodomain_CS | 1.27e-03 | 26 | 38 | 2 | IPR018359 | |
| Domain | RA | 1.81e-03 | 31 | 38 | 2 | SM00314 | |
| Domain | RA | 2.57e-03 | 37 | 38 | 2 | PS50200 | |
| Domain | BROMODOMAIN_1 | 2.57e-03 | 37 | 38 | 2 | PS00633 | |
| Domain | Bromodomain | 2.71e-03 | 38 | 38 | 2 | PF00439 | |
| Domain | UQ_con | 2.85e-03 | 39 | 38 | 2 | PF00179 | |
| Domain | PDZ | 2.93e-03 | 141 | 38 | 3 | PF00595 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 2.99e-03 | 40 | 38 | 2 | PS00183 | |
| Domain | RA_dom | 2.99e-03 | 40 | 38 | 2 | IPR000159 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 3.14e-03 | 41 | 38 | 2 | PS50127 | |
| Domain | BROMODOMAIN_2 | 3.14e-03 | 41 | 38 | 2 | PS50014 | |
| Domain | UBQ-conjugat_E2 | 3.14e-03 | 41 | 38 | 2 | IPR000608 | |
| Domain | BROMO | 3.30e-03 | 42 | 38 | 2 | SM00297 | |
| Domain | Bromodomain | 3.30e-03 | 42 | 38 | 2 | IPR001487 | |
| Domain | - | 3.30e-03 | 42 | 38 | 2 | 1.20.920.10 | |
| Domain | PDZ | 3.36e-03 | 148 | 38 | 3 | SM00228 | |
| Domain | - | 3.49e-03 | 150 | 38 | 3 | 2.30.42.10 | |
| Domain | PDZ | 3.55e-03 | 151 | 38 | 3 | PS50106 | |
| Domain | PDZ | 3.62e-03 | 152 | 38 | 3 | IPR001478 | |
| Domain | FERM_M | 3.94e-03 | 46 | 38 | 2 | PF00373 | |
| Domain | FERM_central | 4.46e-03 | 49 | 38 | 2 | IPR019748 | |
| Domain | FERM_domain | 4.46e-03 | 49 | 38 | 2 | IPR000299 | |
| Domain | - | 4.46e-03 | 49 | 38 | 2 | 1.20.80.10 | |
| Domain | FERM_1 | 4.64e-03 | 50 | 38 | 2 | PS00660 | |
| Domain | FERM_2 | 4.64e-03 | 50 | 38 | 2 | PS00661 | |
| Domain | Band_41_domain | 4.64e-03 | 50 | 38 | 2 | IPR019749 | |
| Domain | B41 | 4.64e-03 | 50 | 38 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 4.64e-03 | 50 | 38 | 2 | IPR014352 | |
| Domain | FERM_3 | 4.64e-03 | 50 | 38 | 2 | PS50057 | |
| Domain | - | 4.83e-03 | 51 | 38 | 2 | 3.10.110.10 | |
| Domain | UBQ-conjugating_enzyme/RWD | 5.20e-03 | 53 | 38 | 2 | IPR016135 | |
| Domain | CH | 7.73e-03 | 65 | 38 | 2 | SM00033 | |
| Domain | CH | 8.92e-03 | 70 | 38 | 2 | PF00307 | |
| Domain | - | 9.17e-03 | 71 | 38 | 2 | 1.10.418.10 | |
| Domain | SH3 | 9.55e-03 | 216 | 38 | 3 | PS50002 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 6.10e-05 | 42 | 26 | 3 | MM15677 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 6.10e-05 | 42 | 26 | 3 | M41826 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 6.10e-05 | 42 | 26 | 3 | M41828 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 6.55e-05 | 43 | 26 | 3 | MM15679 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 6.55e-05 | 43 | 26 | 3 | M41827 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 7.02e-05 | 44 | 26 | 3 | MM15678 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.05e-03 | 110 | 26 | 3 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.29e-03 | 118 | 26 | 3 | M27316 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 1.38e-03 | 30 | 26 | 2 | M257 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 1.38e-03 | 30 | 26 | 2 | M27762 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 1.38e-03 | 30 | 26 | 2 | MM15507 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 1.90e-03 | 135 | 26 | 3 | M15247 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.09e-03 | 37 | 26 | 2 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 2.09e-03 | 37 | 26 | 2 | MM15610 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 2.32e-03 | 39 | 26 | 2 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 2.44e-03 | 40 | 26 | 2 | M41816 | |
| Pubmed | 4.00e-07 | 130 | 40 | 5 | 12421765 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 32364818 | ||
| Pubmed | 4.04e-06 | 27 | 40 | 3 | 18685082 | ||
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | 1.79e-05 | 483 | 40 | 6 | 27107014 | |
| Pubmed | 2.01e-05 | 493 | 40 | 6 | 15368895 | ||
| Pubmed | Histone recognition and large-scale structural analysis of the human bromodomain family. | 2.70e-05 | 7 | 40 | 2 | 22464331 | |
| Pubmed | 3.38e-05 | 1116 | 40 | 8 | 31753913 | ||
| Pubmed | 4.04e-05 | 1497 | 40 | 9 | 31527615 | ||
| Pubmed | S. pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity. | 4.62e-05 | 9 | 40 | 2 | 28162934 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 5.09e-05 | 861 | 40 | 7 | 36931259 | |
| Pubmed | 5.57e-05 | 359 | 40 | 5 | 35559673 | ||
| Pubmed | 9.72e-05 | 77 | 40 | 3 | 19505873 | ||
| Pubmed | 1.02e-04 | 963 | 40 | 7 | 28671696 | ||
| Pubmed | 1.14e-04 | 418 | 40 | 5 | 34709266 | ||
| Pubmed | 1.30e-04 | 225 | 40 | 4 | 12168954 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 16275660 | ||
| Pubmed | 1.89e-04 | 1429 | 40 | 8 | 35140242 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.10e-04 | 1082 | 40 | 7 | 38697112 | |
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 27425610 | ||
| Pubmed | 2.24e-04 | 102 | 40 | 3 | 10231032 | ||
| Pubmed | 2.29e-04 | 486 | 40 | 5 | 20936779 | ||
| Pubmed | 3.39e-04 | 529 | 40 | 5 | 14621295 | ||
| Pubmed | 3.50e-04 | 24 | 40 | 2 | 24647965 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.51e-04 | 533 | 40 | 5 | 30554943 | |
| Pubmed | Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. | 3.80e-04 | 25 | 40 | 2 | 17597759 | |
| Pubmed | 4.45e-04 | 27 | 40 | 2 | 19026994 | ||
| Pubmed | 5.07e-04 | 322 | 40 | 4 | 26514267 | ||
| Pubmed | 5.49e-04 | 329 | 40 | 4 | 17474147 | ||
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 5.87e-04 | 31 | 40 | 2 | 25838543 | |
| Pubmed | 5.92e-04 | 1285 | 40 | 7 | 35914814 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 6.17e-04 | 1294 | 40 | 7 | 30804502 | |
| Pubmed | 6.66e-04 | 33 | 40 | 2 | 26025364 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 6.91e-04 | 150 | 40 | 3 | 28242625 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 6.97e-04 | 1321 | 40 | 7 | 27173435 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.00e-04 | 351 | 40 | 4 | 38297188 | |
| Pubmed | 7.49e-04 | 35 | 40 | 2 | 33864728 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 7.93e-04 | 363 | 40 | 4 | 14691545 | |
| Pubmed | WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. | 9.79e-04 | 40 | 40 | 2 | 29078390 | |
| Interaction | SFN interactions | 5.30e-06 | 692 | 39 | 9 | int:SFN | |
| Interaction | STYK1 interactions | 1.41e-05 | 161 | 39 | 5 | int:STYK1 | |
| Interaction | YWHAE interactions | FANCD2 NAV2 DLG5 AHI1 PTPN13 DST INPP5F RAB11FIP1 UBE2H SAP130 NUAK2 | 1.75e-05 | 1256 | 39 | 11 | int:YWHAE |
| Interaction | DPYSL3 interactions | 2.27e-05 | 86 | 39 | 4 | int:DPYSL3 | |
| Interaction | FTCD interactions | 2.36e-05 | 29 | 39 | 3 | int:FTCD | |
| Interaction | HDAC1 interactions | FANCD2 PHF14 TSHZ3 PTPN13 DST INPP5F PRDM16 SAP130 TFAP4 RCOR2 | 3.57e-05 | 1108 | 39 | 10 | int:HDAC1 |
| Interaction | CBLN1 interactions | 3.64e-05 | 5 | 39 | 2 | int:CBLN1 | |
| Interaction | IGKV3-15 interactions | 5.45e-05 | 6 | 39 | 2 | int:IGKV3-15 | |
| Interaction | KDM1A interactions | 6.07e-05 | 941 | 39 | 9 | int:KDM1A | |
| Interaction | THOC2 interactions | 6.17e-05 | 219 | 39 | 5 | int:THOC2 | |
| Interaction | CTBP2 interactions | 7.19e-05 | 370 | 39 | 6 | int:CTBP2 | |
| Interaction | MAPRE3 interactions | 7.78e-05 | 230 | 39 | 5 | int:MAPRE3 | |
| Interaction | SMAD2 interactions | 8.95e-05 | 385 | 39 | 6 | int:SMAD2 | |
| Interaction | PCNT interactions | 9.69e-05 | 241 | 39 | 5 | int:PCNT | |
| Interaction | RBBP4 interactions | 1.01e-04 | 573 | 39 | 7 | int:RBBP4 | |
| Interaction | YWHAB interactions | 1.08e-04 | 1014 | 39 | 9 | int:YWHAB | |
| Interaction | CTBP1 interactions | 1.20e-04 | 406 | 39 | 6 | int:CTBP1 | |
| Interaction | FRMPD4 interactions | 1.30e-04 | 9 | 39 | 2 | int:FRMPD4 | |
| Interaction | YWHAZ interactions | FANCD2 NAV2 DLG5 DMXL2 PTPN13 DST INPP5F RAB11FIP1 UBE2H NUAK2 | 1.54e-04 | 1319 | 39 | 10 | int:YWHAZ |
| Interaction | YWHAH interactions | 2.02e-04 | 1102 | 39 | 9 | int:YWHAH | |
| Interaction | DNM2 interactions | 2.23e-04 | 288 | 39 | 5 | int:DNM2 | |
| Interaction | ACTL6A interactions | 2.26e-04 | 289 | 39 | 5 | int:ACTL6A | |
| Interaction | TAF4 interactions | 2.30e-04 | 156 | 39 | 4 | int:TAF4 | |
| Interaction | SOX6 interactions | 2.36e-04 | 157 | 39 | 4 | int:SOX6 | |
| Interaction | EML6 interactions | 2.38e-04 | 12 | 39 | 2 | int:EML6 | |
| Interaction | PARD3 interactions | 2.61e-04 | 298 | 39 | 5 | int:PARD3 | |
| Interaction | LSM12 interactions | 2.78e-04 | 164 | 39 | 4 | int:LSM12 | |
| Interaction | MYBPH interactions | 2.81e-04 | 13 | 39 | 2 | int:MYBPH | |
| Interaction | CAP2 interactions | 2.82e-04 | 66 | 39 | 3 | int:CAP2 | |
| Interaction | CP interactions | 2.95e-04 | 67 | 39 | 3 | int:CP | |
| Interaction | RRP1 interactions | 3.26e-04 | 171 | 39 | 4 | int:RRP1 | |
| Interaction | S100A14 interactions | 3.50e-04 | 71 | 39 | 3 | int:S100A14 | |
| Interaction | TEX10 interactions | 3.56e-04 | 175 | 39 | 4 | int:TEX10 | |
| Interaction | RAB5A interactions | 3.64e-04 | 706 | 39 | 7 | int:RAB5A | |
| Interaction | MOB1A interactions | 3.64e-04 | 72 | 39 | 3 | int:MOB1A | |
| Interaction | POU2F3 interactions | 3.77e-04 | 15 | 39 | 2 | int:POU2F3 | |
| Interaction | GGCT interactions | 3.79e-04 | 73 | 39 | 3 | int:GGCT | |
| Interaction | PPM1G interactions | 3.88e-04 | 325 | 39 | 5 | int:PPM1G | |
| Interaction | HP1BP3 interactions | 4.11e-04 | 329 | 39 | 5 | int:HP1BP3 | |
| Interaction | NUDT5 interactions | 4.11e-04 | 75 | 39 | 3 | int:NUDT5 | |
| Interaction | GOLGA1 interactions | 4.22e-04 | 183 | 39 | 4 | int:GOLGA1 | |
| Interaction | CAV1 interactions | 4.23e-04 | 724 | 39 | 7 | int:CAV1 | |
| Interaction | TRAIP interactions | 4.44e-04 | 77 | 39 | 3 | int:TRAIP | |
| Interaction | CT45A5 interactions | 4.61e-04 | 78 | 39 | 3 | int:CT45A5 | |
| Cytoband | 17q21.32 | 8.48e-04 | 49 | 40 | 2 | 17q21.32 | |
| GeneFamily | PDZ domain containing | 7.98e-04 | 152 | 22 | 3 | 1220 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.13e-03 | 41 | 22 | 2 | 102 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.67e-03 | 50 | 22 | 2 | 1293 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#4 | 1.07e-05 | 73 | 40 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.21e-05 | 109 | 40 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | NAV2 NCKAP5 PTPN13 BCL7A RAB11FIP1 UBE2H PRDM16 TFAP4 UBE2Z RCOR2 | 9.50e-05 | 1275 | 40 | 10 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.35e-07 | 184 | 40 | 5 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.62e-05 | 170 | 40 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.77e-05 | 174 | 40 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.85e-05 | 176 | 40 | 4 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.98e-05 | 179 | 40 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 2.11e-05 | 182 | 40 | 4 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 183 | 40 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-05 | 184 | 40 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-05 | 184 | 40 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 40 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 40 | 4 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.30e-05 | 186 | 40 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.30e-05 | 186 | 40 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 186 | 40 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 186 | 40 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.35e-05 | 187 | 40 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 2.35e-05 | 187 | 40 | 4 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.40e-05 | 188 | 40 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 2.40e-05 | 188 | 40 | 4 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 188 | 40 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-05 | 188 | 40 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-05 | 190 | 40 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 2.55e-05 | 191 | 40 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 192 | 40 | 4 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.66e-05 | 193 | 40 | 4 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.66e-05 | 193 | 40 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.66e-05 | 193 | 40 | 4 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.71e-05 | 194 | 40 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 195 | 40 | 4 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-05 | 195 | 40 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.88e-05 | 197 | 40 | 4 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 198 | 40 | 4 | 2bba5a2f584b00d35d008d9c2d8fb3e712fc3a73 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.94e-05 | 198 | 40 | 4 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 3.00e-05 | 199 | 40 | 4 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 3.00e-05 | 199 | 40 | 4 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 136 | 40 | 3 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-13|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-04 | 144 | 40 | 3 | b2a9f3b5dd46d27689467f4a5fd717cd5827821f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-04 | 146 | 40 | 3 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 3.21e-04 | 149 | 40 | 3 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-04 | 150 | 40 | 3 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 152 | 40 | 3 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 153 | 40 | 3 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.54e-04 | 154 | 40 | 3 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-04 | 155 | 40 | 3 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-04 | 156 | 40 | 3 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.75e-04 | 157 | 40 | 3 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.75e-04 | 157 | 40 | 3 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.82e-04 | 158 | 40 | 3 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 161 | 40 | 3 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 161 | 40 | 3 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 161 | 40 | 3 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.11e-04 | 162 | 40 | 3 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T7|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.11e-04 | 162 | 40 | 3 | c6ace47daf32495b25793d39b72382978349597d | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.18e-04 | 163 | 40 | 3 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.33e-04 | 165 | 40 | 3 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 165 | 40 | 3 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 165 | 40 | 3 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.41e-04 | 166 | 40 | 3 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.41e-04 | 166 | 40 | 3 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.41e-04 | 166 | 40 | 3 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.49e-04 | 167 | 40 | 3 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-04 | 168 | 40 | 3 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.56e-04 | 168 | 40 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-04 | 170 | 40 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-04 | 170 | 40 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-04 | 170 | 40 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.97e-04 | 173 | 40 | 3 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 5.06e-04 | 174 | 40 | 3 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.14e-04 | 175 | 40 | 3 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-04 | 176 | 40 | 3 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.23e-04 | 176 | 40 | 3 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.31e-04 | 177 | 40 | 3 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-04 | 177 | 40 | 3 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 5.31e-04 | 177 | 40 | 3 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.40e-04 | 178 | 40 | 3 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.49e-04 | 179 | 40 | 3 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 5.58e-04 | 180 | 40 | 3 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.58e-04 | 180 | 40 | 3 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.58e-04 | 180 | 40 | 3 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.58e-04 | 180 | 40 | 3 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | fbe5bdd642b86010dbef0a567b25c69c7335688f | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.76e-04 | 182 | 40 | 3 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.76e-04 | 182 | 40 | 3 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | fe4fb213dc0ca482b0f94097fe1b0a51fc2690e2 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-04 | 183 | 40 | 3 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 5.85e-04 | 183 | 40 | 3 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.95e-04 | 184 | 40 | 3 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-04 | 184 | 40 | 3 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.95e-04 | 184 | 40 | 3 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-04 | 184 | 40 | 3 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 5.95e-04 | 184 | 40 | 3 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-04 | 184 | 40 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.95e-04 | 184 | 40 | 3 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 1.79e-05 | 5 | 40 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 1.79e-05 | 5 | 40 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 1.79e-05 | 5 | 40 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 3.36e-05 | 46 | 40 | 3 | EFO_0008003, GO_0097332 | |
| Disease | neuroimaging measurement | 7.92e-05 | 1069 | 40 | 8 | EFO_0004346 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.38e-04 | 194 | 40 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.38e-04 | 13 | 40 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Fanconi Anemia | 5.27e-04 | 25 | 40 | 2 | C0015625 | |
| Disease | eicosapentaenoic acid measurement | 8.13e-04 | 31 | 40 | 2 | EFO_0007760 | |
| Disease | brain measurement, neuroimaging measurement | 8.48e-04 | 550 | 40 | 5 | EFO_0004346, EFO_0004464 | |
| Disease | retinal detachment, retinal break | 1.04e-03 | 35 | 40 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | FEV/FEC ratio | 1.19e-03 | 1228 | 40 | 7 | EFO_0004713 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.56e-03 | 43 | 40 | 2 | DOID:2476 (implicated_via_orthology) | |
| Disease | selective IgA deficiency disease | 1.79e-03 | 46 | 40 | 2 | EFO_1001929 | |
| Disease | peak expiratory flow | 4.53e-03 | 498 | 40 | 4 | EFO_0009718 | |
| Disease | alcoholic liver disease | 5.56e-03 | 82 | 40 | 2 | EFO_0008573 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EHSFSGSDSEDSELM | 956 | Q96Q91 | |
| DTSHEKVESMSESDT | 21 | Q8TC20 | |
| DLSSSDSSDSESEMF | 656 | Q58F21 | |
| SVSSDSHQDDEISSM | 271 | Q8N157 | |
| SHQDDEISSMEQSTE | 276 | Q8N157 | |
| DSSNAEEAAMQDHST | 1286 | Q8TDJ6 | |
| EDDSGEASSQNSMSS | 281 | Q8TF21 | |
| DSADSAVSTDSSMDE | 386 | Q6ZP65 | |
| HSMSSRRDTDSDTQD | 706 | Q9Y2H0 | |
| MTDDESESVLSDSHE | 1 | Q9H0I3 | |
| NDEDSDTGLSSMHSQ | 481 | A6NK89 | |
| SEDDSSEEEHSHDSM | 31 | Q8IZ40 | |
| HHSSTSNQETSDSEM | 441 | Q6VN20 | |
| MDSVSVSSCESNHSE | 551 | Q9NZL6 | |
| EFHSDTDHLDSMQSE | 2566 | Q03001 | |
| ASETEENGSDSFMHS | 636 | Q05193 | |
| SIHDDSDSSNSDNDT | 226 | Q8N4E4 | |
| AHSSHDSAIDTDSME | 601 | Q8TDM6 | |
| RSSASSSDSDEMDYD | 391 | Q53F19 | |
| NEDDVEIMSTDSSSS | 251 | Q9NPJ6 | |
| ESDSIMSSASENSTE | 356 | O94880 | |
| SDEEHMEEAITSASF | 366 | Q15884 | |
| EESSSDSDMGFHESQ | 61 | Q96BT1 | |
| DSGNETNSSEMTESS | 906 | Q14CM0 | |
| EDASDEQNSQSSMEH | 146 | Q4VC05 | |
| ESDGDMSSDNDSYHS | 846 | Q9Y2H2 | |
| DESQESSMTDADDTQ | 801 | P30260 | |
| SSMTDADDTQLHAAE | 806 | P30260 | |
| ESTADESEDDMSSQA | 1406 | Q9BXW9 | |
| SDMDEATYSSSQDHQ | 1321 | Q12923 | |
| DNEDESSSASDVMSH | 261 | Q6WKZ4 | |
| HMVVDEDSRSESSST | 161 | O14513 | |
| TAAIMSDSDSEEDSS | 16 | Q8IZX4 | |
| SHSAEDEAEDSAMSP | 31 | Q9HAZ2 | |
| SASSHSDIEEMTDSS | 1851 | Q8IVL1 | |
| NDMAQSLHSDTADDT | 381 | Q9H093 | |
| SESSMSDFSEDEAQD | 166 | P62256 | |
| DSEVSAREHMSSSSS | 71 | Q9H0E3 | |
| ENAEMDSDSSSSGTE | 331 | Q9H832 | |
| SHISETSDRMADFES | 76 | Q63HK5 | |
| MVDNDSSGTSDKDHS | 301 | Q96RS0 | |
| MDEEASQESSSHDNV | 526 | Q96RS0 | |
| HDASTSSDSEEQDMS | 541 | Q96RS0 | |
| DTASDSEASDSDAMD | 311 | Q01664 | |
| EHNSSLMVSESEFDS | 1021 | Q5VV43 | |
| SSSATDSSMEEIFQH | 566 | P20591 |